Advertisement

Document › Details
Waters Corporation. (1/15/19). "Press Release: Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System". Milford, MA.
![]() |
Organisation | Waters Corporation (NYSE: WAT) |
Group | Waters (Group) | |
Organisation 2 | Pfizer Inc. (NYSE: PFE) | |
Group | Pfizer (Group) | |
![]() |
Product | BioAccord™ LC-MS System |
Product 2 | ACQUITY RDa™ Detector featuring SmartMS™ | |
![]() |
Person | O’Connell, Christopher J. (Chris) (Waters 201509–202009 CEO before over 21 years at Medtronic) |
Person 2 | Tarmy, Jeff (Waters 201005) | |
As the Number of Analytical Monitoring Tests for Biopharmaceuticals Skyrockets, Waters Builds Intelligence into a Fit-for-Purpose System
Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand access to high-resolution time-of-flight mass spectrometry capabilities to more scientists. The BioAccord System promises to move routine monitoring out of centralized MS labs and into the hands of more scientists by enabling more effective analysis of biotherapeutic protein attributes across development and within quality control organizations.
"The pace of innovation in the biopharmaceutical industry is accelerating, and with it, the monitoring requirements for biotherapeutics are growing exponentially," said Chris O'Connell, Chairman and CEO, Waters Corporation. "The inherent complexity of these therapies, combined with rising regulatory standards, are driving more intensive and widespread testing requirements. Waters designed the BioAccord System as a fit-for-purpose LC-MS biopharmaceutical solution to deliver rich mass spectrometry data for improved productivity and effective decision-making."
The BioAccord System pairs ACQUITYTM UPLC™ I-Class Plus with the newly-developed ACQUITY RDa™ Detector featuring SmartMS™. This system offers new levels of user experience with automated setup and self diagnosis delivered through an intuitive user interface, all within a surprisingly small footprint. Powered by UNIFI™, Waters’ compliance-ready LC-MS informatics platform, the BioAccord System has been optimized for intact protein, released glycan, and peptide monitoring applications, and streamlined by the use of Waters' application-specific chemistries and consumables kits.
The first public exhibition of the BioAccord System will take place at the Well Characterized Biopharmaceutical Conference (WCBP) in Washington D.C. On Tuesday, January 29, at WCBP, Waters will sponsor a lunch seminar in the Palm Court Room at the Mayflower Hotel from 12:45 – 1:45 p.m. titled: High Performance LCMS Analysis in Biopharma: From Molecular Characterization to Routine Monitoring featuring Dr. John Gebler, Director, Biopharmaceutical, Waters Corporation. Guest speaker, Dr. Mellisa M. Ly, Principal Scientist from Pfizer, Inc. will expand on the topic presenting, Characterizing and Monitoring Quality Attributes in Monoclonal Antibodies using a High Resolution, Small Footprint LC-MS System.
Additionally, customers are invited to visit www.waters.com/bioaccord for a deeper understanding of the new BioAccord LC-MS system.
The BioAccord System is currently available for customer shipments worldwide.
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Jeff Tarmy
508-482-2268
jeff_tarmy@waters.com
Record changed: 2023-06-05 |
Advertisement

More documents for Waters (Group)
- [1] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....
- [2] Waters Corporation. (5/16/23). "Press Release: Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology". Milford, MA....
- [3] Waters Corporation. (2/15/23). "Press Release: Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader". Milford, MA....
- [4] Waters Corporation. (12/20/22). "Press Release: Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live". Milford, MA....
- [5] Scitara Corporation. (6/20/22). "Press Release: Jeffrey R. Mazzeo, PhD Joins Scitara to Lead New Marketing Initiatives as Chief Marketing Officer". Marlborough, MA....
- [6] Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo....
- [7] Waters Corporation. (10/27/21). "Press Release: Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development". Milford, MA & Göttingen....
- [8] Waters Corporation. (10/20/21). "Press Release: Waters and University of Delaware Announce Bioprocessing Innovation Partnership, Plan 2022 Opening of Immerse Delaware Lab". Milford, MA & Newark, DE....
- [9] AB Sciex (d/b/a Sciex). (5/11/21). "Press Release: Sciex and Waters Corporation Collaborate Up to Deliver Fully Configured and Interoperable LC-MS Systems". Framingham, MA & Milford, MA....
- [10] Genovis AB. (4/13/21). "Press Release: Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization"....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top